Literature DB >> 1378512

Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C.

K E Dolter1, W F Goins, M Levine, J C Glorioso.   

Abstract

Herpes simplex virus type 1 (HSV-1) glycoprotein C (gC-1) elicits a largely serotype-specific immune response directed against previously described determinants designated antigenic sites I and II. To more precisely define these two immunodominant antigenic regions of gC-1 and to determine whether the homologous HSV-2 glycoprotein (gC-2) has similarly situated antigenic determinants, viral recombinants containing gC chimeric genes which join site I and site II of the two serotypes were constructed. The antigenic structure of the hybrid proteins encoded by these chimeric genes was studied by using gC-1- and gC-2-specific monoclonal antibodies (MAbs) in radioimmunoprecipitation, neutralization, and flow cytometry assays. The results of these analyses showed that the reactivity patterns of the MAbs were consistent among the three assays, and on this basis, they could be categorized as recognizing type-specific epitopes within the C-terminal or N-terminal half of gC-1 or gC-2. All MAbs were able to bind to only one or the other of the two hybrid proteins, demonstrating that gC-2, like gC-1, contains at least two antigenic sites located in the two halves of the molecule and that the structures of the antigenic sites in both molecules are independent and rely on limited type-specific regions of the molecule to maintain epitope structure. To fine map amino acid residues which are recognized by site I type-specific MAbs, point mutations were introduced into site I of the gC-1 or gC-2 gene, which resulted in recombinant mutant glycoproteins containing one or several residues from the heterotypic serotype in an otherwise homotypic site I background. The recognition patterns of the MAbs for these mutant molecules demonstrated that (i) single amino acids are responsible for the type-specific nature of individual epitopes and (ii) epitopes are localized to regions of the molecule which contain both shared and unshared amino acids. Taken together, the data described herein established the existence of at least two distinct and structurally independent antigenic sites in gC-1 and gC-2 and identified subtle amino acid sequence differences which contribute to type specificity in antigenic site I of gC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378512      PMCID: PMC241321     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.

Authors:  M F Para; M L Parish; A G Noble; P G Spear
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

2.  Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies.

Authors:  J Koga; S Chatterjee; R J Whitley
Journal:  Virology       Date:  1986-06       Impact factor: 3.616

3.  The nucleotide sequence of the gB glycoprotein gene of HSV-2 and comparison with the corresponding gene of HSV-1.

Authors:  D J Bzik; C Debroy; B A Fox; N E Pederson; S Person
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

4.  Base composition-independent hybridization in tetramethylammonium chloride: a method for oligonucleotide screening of highly complex gene libraries.

Authors:  W I Wood; J Gitschier; L A Lasky; R M Lawn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

5.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.

Authors:  S D Showalter; M Zweig; B Hampar
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

7.  Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates.

Authors:  H M Friedman; J C Glorioso; G H Cohen; J C Hastings; S L Harris; R J Eisenberg
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

8.  Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA.

Authors:  F L Homa; T M Otal; J C Glorioso; M Levine
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

9.  Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody.

Authors:  F L Homa; D J Purifoy; J C Glorioso; M Levine
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

10.  Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2.

Authors:  R J Eisenberg; M Ponce de Leon; H M Friedman; L F Fries; M M Frank; J C Hastings; G H Cohen
Journal:  Microb Pathog       Date:  1987-12       Impact factor: 3.738

View more
  7 in total

1.  Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling.

Authors:  Mina Kalantari-Dehaghi; Sookhee Chun; Aziz Alami Chentoufi; Jozelyn Pablo; Li Liang; Gargi Dasgupta; Douglas M Molina; Algis Jasinskas; Rie Nakajima-Sasaki; Jiin Felgner; Gary Hermanson; Lbachir BenMohamed; Philip L Felgner; D Huw Davies
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

Review 2.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

3.  Conservation of type-specific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates.

Authors:  J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.

Authors:  S Laquerre; R Argnani; D B Anderson; S Zucchini; R Manservigi; J C Glorioso
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules.

Authors:  R Tal-Singer; C Peng; M Ponce De Leon; W R Abrams; B W Banfield; F Tufaro; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  Resistance of herpes simplex virus type 2 to neomycin maps to the N-terminal portion of glycoprotein C.

Authors:  A M Oyan; K E Dolter; N Langeland; W F Goins; J C Glorioso; L Haarr; C S Crumpacker
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

7.  Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.

Authors:  S Laquerre; D B Anderson; D B Stolz; J C Glorioso
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.